Evotec Investor Presentation Deck
evotec
Molecular patient
databases
Re-defining health and
disease via molecular
disease profiles
EVOpanOmics
EVO panHunter
PAGE 13
E.IPSC
DRUG DISCOVERY
Precision medicine is the only path to improved medicine
Leading AI/ML driven drug discovery & development platforms
Targeted disease models &
precision medicine approaches
Focus on early
disease relevance
Clinical diagnostics
and biomarkers
Precision diagnostics and
tracking of diseases
• Transcriptomics and proteomics data at industrial scale
Multiple patient-derived data bases, e.g. CKD database (>10,000 patients; >600 billion data points)
• User friendly AI/ML driven multi-omics analysis platform
• Exceeding industry standards in predicting drug safety (e.g.: liver injury 86% vs. 70%)
One of the largest and most sophisticated iPSC platforms for drug discovery in industry
• First iPSC-derived drug candidate in clinic, large pipeline evolving in drug discovery and cell therapy
-I-View entire presentation